Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74 | 62 | 988 | 1,997 | N/A |
| Receivables | 19 | 49 | 62 | 98 | 98 |
| Other current assets | 164 | 0 | 0 | 0 | 150 |
| TOTAL | $329 | $196 | $1,139 | $2,285 | $248 |
| Non-Current Assets | |||||
| PPE Net | 33 | 23 | 18 | N/A | 0 |
| Intangibles | 0 | 0 | 0 | 320 | 0 |
| Other Non-Current Assets | 9 | 19 | 4 | 29 | 0 |
| TOTAL | $41 | $42 | $22 | $349 | $N/A |
| Total Assets | $370 | $238 | $1,161 | $2,634 | $248 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6 | 27 | 96 | 139 | N/A |
| Accounts payable and accrued liabilities | 1,741 | 1,484 | 1,286 | 336 | 0 |
| Accrued Expenses | 835 | 866 | 859 | 980 | N/A |
| Other current liabilities | 4,801 | 2,062 | N/A | N/A | 70 |
| TOTAL | $11,781 | $4,438 | $2,241 | $1,454 | $120 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 25 | 119 | 119 |
| TOTAL | $10 | $3 | $30 | $126 | $119 |
| Total Liabilities | $11,792 | $4,442 | $2,271 | $1,581 | $239 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 56 | 42 | 25 | N/A |
| Retained earnings | -42,237 | -33,370 | -25,196 | -16,674 | N/A |
| TOTAL | $-11,422 | $-4,204 | $-1,110 | $1,053 | $N/A |
| Total Liabilities And Equity | $370 | $238 | $1,161 | $2,634 | $239 |